Advertisement

Topics

Synthon Chiragenics Corporation Company Profile

13:44 EST 13th December 2018 | BioPortfolio

Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for decades, carbohydrate chemistry has eluded researchers because of the complexity of the molecules and the difficulty of working with them. Synthon is the first and only company to unlock the rich source of chirality contained in naturally occurring carbohydrates. The company uses its proprietary technology to economically construct the most challenging chiral molecules, which serve as cores for drugs being developed in the fastest-growing therapeutic areas: anti-virals, antibiotics and anti-cancer.These "drugs of the future" are the most difficult and expensive to make because they possess multiple chiral centers. The company's strategy is to start with naturally occurring, readily available carbohydrates that have the chirality already built-in. Carbohydrates are unique because they have multiple contiguous chiral centers, which can be manipulated to form desired drug intermediates more cost-effectively than other methods.

Location

7 Deer Park Drive
Monmouth Junction
New Jersey
08852
United States of America

Contact

Phone: 732-274-0037
Fax: 732-274-0502
Email: info@synthoncorp.com


News Articles [83 Associated News Articles listed on BioPortfolio]

47 Scoop: Trillium Bleeds, Surface Hemorrhages, And Forty Seven Throws In The $47 Million Towel On Synthon Lawsuit

Orion Corporation: Managers' transactions - EVK-Capital Oy

ORION CORPORATION      MANAGERS' TRANSACTIONS 31 MAY 2018 at 18.30 EEST              Orion Corporation: Managers' transactions - EVK-Capital Oy Orion Corp...

Ambu A/S: Articles of Association November 2018

  Attached the updated Articles of Association November 2018 Complete Articles of Association November 2018This announcement is distributed by West Corporation on behalf of West Corporation...

Ambu A/S: Articles of Association December 2018

  Attached Complete Articles of Association December 2018 Complete Articles of Association December 2018This announcement is distributed by West Corporation on behalf of West Corporation cl...

Orion Corporation: Managers' transactions - Anne Karvonen

ORION CORPORATION      MANAGERS' TRANSACTIONS 20 June 2018 at 11.45 EEST Orion Corporation: Managers' transactions - Anne Karvonen Orion Corporation has received the fo...

Orion Corporation: Managers' transactions - Nina Karvonen

ORION CORPORATION         MANAGERS' TRANSACTIONS 20 June 2018 at 12.00 EEST Orion Corporation: Managers' transactions - Nina Karvonen Orion Corporation has recei...

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18 September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of NOK 10.58 per share. Following this sa...

International Endeavors Corporation Hires Marketing Director

TEMECULA, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--International Endeavors Corporation (OTC:IDVV) announces the hiring of William Vinson as Marketing Director to expand sales of t...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

Diversity-oriented approach towards the syntheses of amaryllidaceae alkaloids via a common chiral synthon.

Functionalized hydroindole (1), a common chiral synthon, for versatile transformations to synthesize broad range of amaryllidaceae alkaloids (AA) including (-)-crinine, (-)-crinane, (-)-amabiline, (+)...

Sustainable Phosphorus Chemistry: A Silylphosphide Synthon for the Generation of Value-Added Phosphorus Chemicals.

Avoiding white phosphorus: Cummins and Geeson have recently described the conversion of phosphoric acid into the novel bis(trichlorosilyl)phosphide anion, which serves as a key intermediate in the syn...

Rh(III)-Catalyzed 4 + 2 Self-Annulation of N-Vinylarylamides.

An efficient rhodium(III)-catalyzed self-annulation of N-vinylarylamide has been developed. This reaction features a simple system and good reactivity with complete regioselectivity. The protocol prov...

A C CO dispensing system for rapid screening of carbonylation reactions.

[ C] CO is a highly versatile synthon that allows for labeling at carbonyl positions of many molecules by means of transition metal-mediated carbonylation reactions. The intrinsic complexity of carbon...

Preparation of Pyrimidine Alkenyl Acyclic Nucleoside Phosphonoamidates.

This synthetic protocol describes two strategies for the preparation of pyrimidine alkenyl acyclic nucleoside phosphonoamidates (ANPs), including linear and trisubstituted alkenyl derivatives. For the...

Clinical Trials [0 Results]

None

Companies [181 Associated Companies listed on BioPortfolio]

Synthon Chiragenics Corporation

Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for deca...

Synthon Biopharmaceuticals

Synthon, with headquarters in Nijmegen, the Netherlands, is an international pharmaceutical company and a leader in the field of generic medicines. The company started its biophar...

Synthon Pharmaceuticals, Inc.

Synthon is an independent group of affiliated pharmaceutical companies dedicated to the development, registration, production, marketing and distribution of a wide range of pharmaceutical products. Fo...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Synthon Chiragenics Corporation" on BioPortfolio

We have published hundreds of Synthon Chiragenics Corporation news stories on BioPortfolio along with dozens of Synthon Chiragenics Corporation Clinical Trials and PubMed Articles about Synthon Chiragenics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Synthon Chiragenics Corporation Companies in our database. You can also find out about relevant Synthon Chiragenics Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record